03/19/2026
Neuromonitoring made national news (again), this time for accusations of fraudulent billing and racketeering (RICO).
STAT/The Boston Globe published a 19-page investigative report (it's juicy). I have no firsthand knowledge of the validity of any/all allegations, so I don't care to go there. Google or ChatGPT will get you up to speed faster than I can.
The less headline-grabbing takeaway is the one worth sitting with: how each of us thinks about compliance and risk.
As in a hospital, a surgeon, a direct employee, or someone in the IONM field.
If you're a hospital administrator contracting with an IONM group, the question isn't whether your vendor is the one in the article. It's whether you know how they bill and if their structure is aligned for compliance or revenue extraction.
Do they balance bill? Do they keep billing in-house or outsource it on contingency? Do you know the org structure behind the group delivering and billing for care? Have you ever asked or requested attestations? Most haven't.
The NSA was built to protect patients from balance billing, but it shifted the risk, and that risk just got a lot more visible.
If you're a surgeon, the chances of being presented with a financial arrangement tied to neuromonitoring utilization aren't zero.
The 2023 OIG statement made the legal gray area real. And where lawsuits once targeted the monitoring company, the Texas Medical Board recently went after the surgeon. The risk shifted as the landscape changed.
If you're an IONM physician or clinician, the company you work for shapes your professional reputation whether you want it to or not.
You're the face in the OR, building trust with surgical staff, and when a patient gets balance billed or questions why neuromonitoring costs more than the surgeon, that lands on you, even when it's out of your control. That's lost business and contracts, regardless of the quality of care you deliver.
Knowing how your organization functions beyond the OR matters.
And if you're in the field working for a group choosing compliance as their billing model, you're not off the hook. The burden of proof falls at your feet due to proximity. There's as much risk in keeping quiet as there is in speaking up. Do or don't, just understand your choice.
____
The IONM field has spent years building clinical legitimacy. Cases like this don't destroy it. But they do put pressure on everyone to know who they're working with and what they're attached to.
The question worth sitting with isn't "is the company doing any of this?" It's "do I actually know enough to answer that with confidence, and what does it mean for me?"
If the answer is no, that's where to start.